Healthcare tech company Medivolve launches initiative to hire more than 30 engineers and software developers
Continued Rapid Growth – Medivolve Creates Jobs for Next Generation SaaS Application Development to Improve Patient Care
TORONTO, August 10, 2021 / PRNewswire / – Medivolve inc. (“Medivolve“or the”Society“) (NEO: MEDV) (OTC: COPRF) (FRA: 4NC) has announced plans to expand its presence by creating at least 30 new jobs over the next 18 months in its design and engineering fields , information technology, project management and software development teams.
Currently employing 237 people across Canada and United States, this expansion will increase Medivolve’s workforce by more than 13% and help meet the increased demand for digital healthcare transformation, originally fueled by COVID-19.
“Medivolve is committed to unlocking multiple sources of revenue by providing the best telehealth services to our patients,” shares David Preiner, CEO of Medivolve. “Hiring a team of quality engineers and software developers is essential to maintain our rapid growth rate, while developing successful applications and effectively bringing them to market. “
Competition for recruitment in the technology development industry is fierce. “Medivolve examines all opportunities to identify and attract new talent. With the recruitment plans in place, we are confident that we will find world-class technical experts, who will fill a variety of hyper-specialized roles, ”said Preiner.
The majority of Medivolve’s job openings will include software engineers and developers for iOS, Android, Java and other platforms, building on the company’s current software foundation aimed at troubleshooting issues. health of millions of people.
“Growing our workforce is an integral part of our overall strategy and also provides transformational employment opportunities to fulfill our mission by not only building a motivated team that is empowered to improve patient outcomes, but also reshape the landscape of healthcare as a whole, ”concludes Preiner.
Passionate about new technologies and improving America’s healthcare system, applicants should demonstrate excellent technical skills, strong motivation, and be prepared to take on ambitious challenges. To submit a request, visit the Medivolve website at: www.medivolve.net
About Medivolve, Inc.
Medivolve, Inc. (NEO: MEDV; OTC: COPRF; FRA: 4NC) is a healthcare technology company that seeks to reinvent the US healthcare system by leveraging a bespoke telehealth platform, diagnostic network clinical and data-driven AI framework to improve patient care.
The company was born out of the health crisis; to rethink, relearn and, ultimately, reinvent a better functioning of the health system. Our network of retail collection sites play an important role in recovery by giving all Americans access to fast, accurate, and inexpensive clinical services when and where they need it. These centers will also play a central role in diagnostic tests, vaccinations and other point-of-care services. We develop disruptive technologies to make it easier and faster to identify, treat and prevent medical problems. In doing so, we strive to give patients a holistic and empowered view of their personal health.
Our long-term mission is to permanently solve systemic problems in the country’s fragmented, overly complex and costly healthcare system. Medivolve’s next phase of growth is to rotate the model and put the pieces together to create a profitable, SaaS-based healthcare technology business. We bring data-driven clinical diagnostics, physician referrals, and prescription drugs directly to people, all powered by a single, streamlined technology network. Our team is united by a powerful and singular goal: to harness the transformative power of technology to create healthier lives.
Backed by a bespoke AI-driven platform, we are developing a stealth system that constantly gets smarter, takes the guesswork out of diagnoses, and immediately reports critical health issues to deliver an unmatched level of personalization for every patient. We are committed to pushing the boundaries of what is possible, not only for our company and our shareholders, but for physicians and patients, and for the future of healthcare. We strive to achieve never-before-seen continuity of care, a game changer for our business and for the patients in the communities we serve.
Caution regarding forward-looking information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Forward-looking information includes, without limitation, statements regarding the hiring and engagement of engineers and software developers; or advancing revenue streams and business models for Medivolve. In general, forward-looking information can be identified by the use of forward-looking terms such as “plans”, “expects” or “does not expect”, “is planned”, “budget”, “planned”, “Estimates”, “foresees”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or declares that certain actions, events or results ” could ”,“ could ”,“ could ”,“ could ”or“ will be taken ”,“ occur ”or“ be reached ”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, are significantly different from those expressed or implied. by this forward-looking information. Although the Company has attempted to identify important factors which could cause actual results to differ materially from those contained in forward-looking information, other factors may cause results not to be as anticipated, estimated or planned. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Therefore, readers should not place undue reliance on forward-looking information. The Company does not undertake to update forward-looking information, except in accordance with applicable securities laws.
NEO THE NEO EXCHANGE NOR ITS REGULATORY SERVICE PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS COMMUNICATION.
SOURCE Medivolve Inc.